In 2023, Germany leads Europe in net operating surplus for pharmaceuticals, with Belgium and Spain following. Italy shows a 6.21% increase, indicating significant growth in its pharmaceutical sector. Finland, Greece, and Lithuania also exhibit notable growth rates. Belgium, Netherlands, Austria, and Estonia's figures remain stable year-on-year. Germany faced a slight decrease of 0.11% in 2023.
Future trends to monitor include:
- Italy's continued growth trajectory, potentially elevating its sector influence.
- The stability of Belgium and Netherlands, despite an otherwise dynamic competitive landscape.
- The impact of economic and regulatory changes across the EU on these surpluses.
Top countries in Net Operating Surplus in Basic Pharmaceutical Products and Pharmaceutical Preparations by Country
| # | 10 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 8,350 | 2023 | +1.08% | -0.11% | View data |
| 2 | 2 Belgium | 4,870 | 2023 | +5.97% | View data | |
| 3 | 3 Spain | 3,160 | 2023 | +1.28% | +2.21% | View data |
| 4 | 4 Italy | 2,840 | 2023 | +1.75% | +6.21% | View data |
| 5 | 5 Finland | 1,230 | 2023 | +3.19% | +3.93% | View data |
| 6 | 6 Netherlands | 998 | 2023 | +0.81% | View data | |
| 7 | 7 Austria | 502.23 | 2023 | -1.16% | View data | |
| 8 | 8 Greece | 407.43 | 2023 | +0.66% | +5.22% | View data |
| 9 | 9 Slovenia | 315.7 | 2023 | +2.1% | +0.8% | View data |
| 10 | 10 Lithuania | 75.3 | 2023 | +0.94% | +4.47% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
